MaxCyte, Inc. (MXCT)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Ask a question about MaxCyte, Inc. (MXCT)
Company Performance

Current Price

as of Oct 16, 2024

$3.85

P/E Ratio

N/A

Market Cap

$404.59M

Description

MaxCyte, Inc. engages in the development and licensing of cell-engineering technologies to pharmaceutical and biotechnology companies. Its propriety cell therapy is used in drug discovery and development, and biomanufacturing. Its products include ATx, STx, and GTx instruments. The company was founded by Douglas A. Doerfler on July 31, 1998 and is headquartered in Rockville, MD.

Metrics

Overview

  • HQRockville, MD
  • SectorHealth Technology
  • IndustryBiotechnology
  • TickerMXCT
  • Price$3.85+1.85%

Trading Information

  • Market Cap$404.59M
  • Float92.31%
  • Average Daily Volume (1m)330,738
  • Average Daily Volume (3m)338,598
  • EPS-$0.34

Company

  • Revenue$45.44M
  • Rev Growth (1yr)15.33%
  • Net Income-$9.38M
  • Gross Margin75.82%
  • EBITDA Margin-104.13%
  • EBITDA-$10.86M
  • EV$271.38M
  • EV/Revenue5.97
  • P/EN/A
  • P/S8.87
  • P/B1.82
Documents
SEC Filings
8-K (2024-10-15)
8-K (2024-08-06)
8-K (2024-06-12)
8-K (2024-05-07)
8-K (2024-03-12)
8-K (2024-03-05)
8-K (2024-01-26)
8-K (2024-01-08)
8-K (2023-12-11)
8-K (2023-11-08)
8-K (2023-10-04)
8-K (2023-08-09)
8-K (2023-06-23)
8-K (2023-05-10)
8-K (2023-03-28)
8-K (2023-03-15)
8-K (2023-03-06)
10-Q (2024-08-06)
10-Q (2024-05-07)
10-Q (2023-11-08)
10-Q (2023-08-09)
10-Q (2023-05-10)
10-K (2024-03-12)
10-K (2023-03-15)
Earnings Calls
Earnings Report 2024Q2
Earnings Report 2024Q1
Earnings Report 2023Q4
Earnings Report (2023-11-08)
Earnings Report (2023-08-09)
Factset
Factset Business Description
Factset Street Account
StreetAccount Earnings Call Q&A Summary: MaxCyte Q3 ($3.35, 0.00) (2023-11-08T22:43:23Z)
MaxCyte reports Q3 EPS ($0.11) vs FactSet ($0.10) [6 est, ($0.11)-(0.08)] ($3.35, 0.00) (2023-11-08T21:25:07Z)
MaxCyte initiated buy at Craig-Hallum Capital ($4.68, 0.00) (2023-11-29T12:18:21Z)